Buy rituximab 500mg/50 ml injection (Mabtas 500mg) in bulk from a trusted global pharmaceutical exporter. Reliable supply, competitive pricing, and quality assurance. /rituximab-500mg-50ml-injection-exporter rituximab 500mg/50 ml anticancer injection, rituximab injection supplier, oncology medicines exporter, bulk rituximab supply, monoclonal antibody injection Mabtas 500mg Injection (Rituximab 500mg/50 ml) High-quality monoclonal antibody for oncology and autoimmune therapy β available for reliable global bulk supply Looking to import rituximab 500mg/50 ml in bulk? Partner with a trusted exporter offering consistent quality, verified sourcing, and seamless international delivery. Mabtas 500mg Injection contains rituximab 500mg/50 ml, a widely used monoclonal antibody indicated in the treatment of various cancers and autoimmune disorders. As a targeted therapy, it plays a critical role in modern oncology protocols and immunotherapy regimens. Primecare Impex ensures a stable and compliant supply of rituximab 500mg/50 ml for distributors, hospitals, and procurement agencies worldwide. Brand Name: Mabtas 500mg Injection Generic Name: Rituximab Strength: 500mg/50ml Dosage Form: Injection Packaging: 1 vial (50 ml) Shelf Life: 24 months Category: Anticancer / Monoclonal Antibody Route of Administration: Intravenous infusion Rituximab 500mg/50 ml Dosage Form Sterile liquid injection for intravenous use Strength 500 mg per 50 ml vial Packaging 1 vial of 50 ml per pack Export-grade secure packaging available for bulk shipments Shelf Life 24 Months under recommended storage conditions Therapeutic Uses Rituximab injection is used in the treatment of: Non-Hodgkinβs Lymphoma (NHL) Chronic Lymphocytic Leukemia (CLL) Rheumatoid Arthritis Certain autoimmune disorders Other CD20-positive malignancies Rituximab is a monoclonal antibody that specifically targets the CD20 antigen found on B-cells. By binding to these cells, it: Triggers immune-mediated destruction Induces apoptosis (cell death) Reduces abnormal B-cell populations This targeted mechanism enhances treatment outcomes while minimizing damage to healthy cells. Administered as an intravenous infusion under medical supervision Dosage varies based on indication, patient condition, and treatment protocol Pre-medication may be required to reduce infusion reactions Must be handled by qualified healthcare professionals only Monitor for infusion-related reactions Risk of infections due to immunosuppression Hepatitis B reactivation may occur Not recommended without physician supervision Use with caution in patients with cardiac or pulmonary conditions Always follow regulatory and clinical guidelines during procurement and distribution. Why Choose Primecare Impex Trusted pharmaceutical exporter with proven industry experience Strict quality control and verified sourcing Compliance with international export standards Transparent documentation and regulatory support Competitive bulk pricing for long-term partnerships Dedicated support for importers and distributors Global Export Capability Primecare Impex specializes in bulk export of oncology medicines, including rituximab 500mg/50 ml, to international markets. We offer: Reliable cold-chain logistics (if required) Timely global shipping with secure packaging Documentation support for regulatory compliance Consistent supply for hospitals and distributors Our network ensures smooth delivery across major pharmaceutical markets worldwide. Request a Bulk Quote for Rituximab 500mg/50 ml Today Looking for a dependable supplier of anticancer injections? Get in touch with our export team for pricing, availability, and shipping details. π Website: www.medicineexporterfromindia.com π± WhatsApp: +91 9673008130 Send your inquiry now and secure your supply with a trusted exporter. Oncology Medicines Exporter Monoclonal Antibody Injections Anticancer Drug Wholesale Supply Pharmaceutical Export Services Hospital Bulk Procurement Solutions